ASCO 2019 | Treatments to prevent relapse in AML

Name: Treatments to prevent relapse in AML
Uploaded: 2019-06-01T22:39:40.000Z
Duration: 2 min 48 s
Description: Here, Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, from the University of Birmingham, Birmingham, UK, outlines the therapeutic options that can help address relapse post-transplant in acute myeloid leukemia (AML). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Charles Craddock • 1 Jun 2019

ASCO 2019

Acute Myeloid Leukemia Leukemia Azacitidine Gilteritinib Sorafenib

AMADEUS

Here, Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, from the University of Birmingham, Birmingham, UK, outlines the therapeutic options that can help address relapse post-transplant in acute myeloid leukemia (AML). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.